⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22734054 | 0.94 | — | — | |
| SCHEMBL25899271 | 0.85 | — | — | |
| SCHEMBL25899273 | 0.84 | FAAH (0.30) | — | |
| SCHEMBL22762009 | 0.84 | — | — | |
| SCHEMBL25899274 | 0.83 | FAAH (0.33) | — | |
| SCHEMBL25899275 | 0.83 | FAAH (0.33) | — | |
| SCHEMBL25899278 | 0.82 | — | — | |
| SCHEMBL25899290 | 0.81 | — | — | |
| SCHEMBL25899288 | 0.81 | — | — | |
| SCHEMBL25899291 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230234978-A1 | NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF | Atrium Therapeutics, Inc. | 2023-07-27 | — | — | US | disclosed |